ES2012129A6 - Un metodo para la obtencion de fragmentos de cd4 humana biologicamenteactivos. - Google Patents

Un metodo para la obtencion de fragmentos de cd4 humana biologicamenteactivos.

Info

Publication number
ES2012129A6
ES2012129A6 ES8803064A ES8803064A ES2012129A6 ES 2012129 A6 ES2012129 A6 ES 2012129A6 ES 8803064 A ES8803064 A ES 8803064A ES 8803064 A ES8803064 A ES 8803064A ES 2012129 A6 ES2012129 A6 ES 2012129A6
Authority
ES
Spain
Prior art keywords
fragments
soluble human
uses therefor
hiv
lymphocytes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES8803064A
Other languages
English (en)
Inventor
Ellis Reinherz
Rebecca Hussey
Joseph Sodroski
Neil Richardson
Linda K Clayton
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dana Farber Cancer Institute Inc
Original Assignee
Dana Farber Cancer Institute Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/217,475 external-priority patent/US5109123A/en
Application filed by Dana Farber Cancer Institute Inc filed Critical Dana Farber Cancer Institute Inc
Publication of ES2012129A6 publication Critical patent/ES2012129A6/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70514—CD4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oncology (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

UN METODO PARA LA OBTENCION DE FRAGMENTOS DE CD4 HUMANA BIOLOGICAMENTE ACTIVOS, CARACTERIZADO PORQUE COMPRENDE LAS ETAPAS DE: A) CONSTRUIR UN PLASMIDO RECOMBINANTE QUE PRODUCE CD4 HUMANA SOLUBLE; B) CONTRASFECTAR EL DNA PLASMIDO RECOMBINANTE CON DNA DE VIRUS DE POLIHEDROSIS NUCLEAR AUTOGRAPHA CALIFORNICA (ACNPV) EN CELULAS DE SPODOPTERA FRUGIPERDA (SF9), LO CUAL SE TRADUCE EN LA RECOMBINACION ENTRE LA SECUENCIA RECOMBINANTE DEL PLASMIDO RECOMBINANTE Y LA SECUENCIA GENETICA DE POLIHEDRINA DE ACNPV; C) SELECCIONAR PLACAS NEGATIVAS A LA OCLUSION; D) CULTIVAR LAS PLACAS NEGATIVAS A LA OCLUSION; Y E) RECOGER EL POLIPEPTIDO PRECIPITADO.
ES8803064A 1987-10-08 1988-10-07 Un metodo para la obtencion de fragmentos de cd4 humana biologicamenteactivos. Expired - Lifetime ES2012129A6 (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US10618587A 1987-10-08 1987-10-08
US14431388A 1988-01-14 1988-01-14
US20658588A 1988-06-14 1988-06-14
US07/217,475 US5109123A (en) 1988-06-14 1988-07-11 Alteration of ability of soluble CD4 fragments to bind HIV

Publications (1)

Publication Number Publication Date
ES2012129A6 true ES2012129A6 (es) 1990-03-01

Family

ID=27493499

Family Applications (1)

Application Number Title Priority Date Filing Date
ES8803064A Expired - Lifetime ES2012129A6 (es) 1987-10-08 1988-10-07 Un metodo para la obtencion de fragmentos de cd4 humana biologicamenteactivos.

Country Status (9)

Country Link
EP (1) EP0400010A1 (es)
JP (1) JPH03504234A (es)
AU (1) AU2614888A (es)
DK (1) DK87490A (es)
ES (1) ES2012129A6 (es)
GR (1) GR1000850B (es)
IL (1) IL87902A0 (es)
NZ (1) NZ226475A (es)
WO (1) WO1989003222A1 (es)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5637677A (en) 1987-07-16 1997-06-10 The Trustees Of The University Of Pennsylvania Biologically active compounds and methods of constructing and using the same
ZA887365B (en) * 1987-10-02 1990-05-30 Genentech Inc Adheson variants
US5206353A (en) * 1988-07-23 1993-04-27 The United States Of America As Represented By The Department Of Health And Human Services CD-4/cytotoxic gene fusions
AU623924B2 (en) * 1988-07-22 1992-05-28 United States of America, as represented by the Secretary, U.S. Department of Commerce, The Cytotoxic agent against specific virus infection
EP0408372A1 (en) * 1989-07-13 1991-01-16 Smithkline Beecham Corporation Anti-viral therapy
CA2065010A1 (en) * 1989-08-23 1991-02-24 Brian Seed Non-human primate cd4 polypeptides, fusions thereof, dna encoding, and uses thereof
US5614612A (en) * 1990-03-09 1997-03-25 Haigwood; Nancy L. Purified gp120 compositions retaining natural conformation
JPH0725794B2 (ja) * 1990-03-23 1995-03-22 呉羽化学工業株式会社 新規なペプチド
JPH06504271A (ja) * 1990-09-14 1994-05-19 ザ・トラスティーズ・オブ・ザ・ユニバーシティ・オブ・ペンシルバニア 免疫グロブリンの構造に基づく生物活性なペプチドのデザイン
US7070991B2 (en) 1991-02-08 2006-07-04 Progenics Pharmaceuticals, Inc. Cells expressing a CD4-IgG2 chimeric heterotetramer
AU1438592A (en) * 1991-02-08 1992-09-07 Progenics Pharmaceuticals, Inc. Cd4-gamma1 and cd4-igg1 chimeras
ATE288923T1 (de) 1991-02-08 2005-02-15 Progenics Pharm Inc Cd4-gamma2- und cd4-igg2-chimären
US5234905A (en) * 1991-02-22 1993-08-10 University Of Colorado Foundation, Inc. Soluble CD4 molecules modified to prolong circulating half-life
EP0510483A1 (en) * 1991-04-22 1992-10-28 Boehringer Ingelheim Pharmaceuticals Inc. Method for the detection of viruses
AU2596600A (en) 1998-12-31 2000-07-31 Chiron Corporation Modified hiv env polypeptides
US6602705B1 (en) 1998-12-31 2003-08-05 Chiron Corporation Expression of HIV polypeptides and production of virus-like particles
US7935805B1 (en) 1998-12-31 2011-05-03 Novartis Vaccines & Diagnostics, Inc Polynucleotides encoding antigenic HIV Type C polypeptides, polypeptides and uses thereof
WO2000039304A2 (en) 1998-12-31 2000-07-06 Chiron Corporation Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof
US7211659B2 (en) 2001-07-05 2007-05-01 Chiron Corporation Polynucleotides encoding antigenic HIV type C polypeptides, polypeptides and uses thereof
US20030170614A1 (en) 2001-08-31 2003-09-11 Megede Jan Zur Polynucleotides encoding antigenic HIV type B polypeptides, polypeptides and uses thereof
AU2002316578A1 (en) 2001-08-31 2003-03-18 Chiron Corporation Polynucleotides encoding antigenic hiv type b polypeptides, polypeptides and uses thereof
WO2014150748A2 (en) 2013-03-15 2014-09-25 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Stabilized single human cd4 domains and fusion proteins
WO2017055522A1 (en) 2015-09-29 2017-04-06 Academisch Medisch Centrum Stabilized env proteins of hiv

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE135747T1 (de) * 1986-08-21 1996-04-15 Univ Columbia Für das t-zell oberflächenprotein t4 kodierende dna und verwendung von t4-fragmenten bei der behandlung von aids
PT88641B (pt) * 1987-10-02 1993-04-30 Genentech Inc Metodo para a preparacao de uma variante de adesao

Also Published As

Publication number Publication date
IL87902A0 (en) 1989-03-31
JPH03504234A (ja) 1991-09-19
GR1000850B (el) 1993-02-17
NZ226475A (en) 1991-03-26
AU2614888A (en) 1989-05-02
DK87490A (da) 1990-06-08
WO1989003222A1 (en) 1989-04-20
EP0400010A1 (en) 1990-12-05
DK87490D0 (da) 1990-04-06

Similar Documents

Publication Publication Date Title
ES2012129A6 (es) Un metodo para la obtencion de fragmentos de cd4 humana biologicamenteactivos.
ES8500325A1 (es) Procedimiento para la preparacion de proteinas funcionales de uroquinasa humana.
GR3035627T3 (en) A mammalian cytokine, il-11.
AP9801392A0 (en) Concentrated antibody preparation.
EP1017797A4 (en) NON-ORIGINATING PRIMATE LENTIVIRUS VECTORS AND PACKAGING SYSTEMS
AU4283389A (en) Modified viral glycoproteins, diagnostic and therapeutic uses therefore
ES8702945A1 (es) Un metodo de producir activador de plasminogeno de tejido uterino humano
EP0345462A3 (en) Immunoassay for hiv-1 antigens using f(ab')2 fragments as probe
ES2010727A6 (es) Metodo para producir lineas celulares que producen anticuerpos monoclonales reactivos frente a determinantes antigenicos de gp110 o de p25 de hiv.
EP0296573A3 (en) Novel nucleosides, their preparation and pharmaceutical novel nucleosides, their preparation and pharmaceutical compositions compositions
ATE384795T1 (de) Modifizierte hiv env polypeptide
CA2234263A1 (fr) Composition pharmaceutique contre les tumeurs et infections a papillomavirus
EP0306219A3 (en) Novel hiv proteins and peptides useful in the diagnosis, prophylaxis or therapy of aids
GR862201B (en) Polypeptides and antibodies characteristic of papillomavirus and their application to in vitro diagnosis the prevention and the fight against the infections by the papillomavirus
EP0689586B8 (en) Vpr function and activity
ES8706827A1 (es) Procedimiento para preparar polipeptidos.
EP0344006A3 (en) Peptides that block the binding of hiv-1 to th CD4 receptor protein
WO1991015512A3 (en) Hiv envelope polypeptides
EP0323157A3 (en) Antiviral compounds and methods
EP0160486A3 (en) Monoclonal antibodies
AU1716597A (en) Use of flupirtine for the prophylaxis and therapy of diseases associated with an impairment of the haemopoietic cell system
AU3929589A (en) Human papilloma virus type 57, the dna thereof and the proteins encoded thereby
EP0311228A3 (en) Recombinant polypeptides and their uses, including assay for aids virus
PL329353A1 (en) Novel indications for application of as a drug the agents obtained from smallpox or parapox viruses, possessing many potential ablities, capable to produce parapox immunity
EP0270682A4 (en) NEW COMPLEXES, PROCESS FOR THEIR PREPARATION, AND THEIR MEDICINAL USE.

Legal Events

Date Code Title Description
SA6 Expiration date (snapshot 920101)

Free format text: 2008-10-07